Safety and Effectiveness of Bilastine and Fexofenadine in Perennial Allergic Rhinitis patients
Phase 4
- Conditions
- Health Condition 1: J309- Allergic rhinitis, unspecified
- Registration Number
- CTRI/2024/07/071414
- Lead Sponsor
- Teerthanker Mahaveer Medical College and Research Centre Moradabad
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Patients older than 18 years.
Patient diagnosed with Allergic Rhinitis
Patients diagnosed with perennial allergic rhinitis not on any antihistaminic treatment for past 1 week.
Patient willing to give consent for study
Exclusion Criteria
Patient with a nasal pathology attributing to nasal obstruction.
Patients already on Treatment with Allergic Rhinitis.
Patients on concomitant medication interfering with drug
metabolism.( with CYP3A4 inhibitors like Ketoconazole ,
erythromycin, Clarithromycin, Itraconazole )
Pregnant & Lactating females
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method